Company: NIVFW
Filing Date: 2025-03-07
Form Type: F-1
Source: 0001213900-25-021404
Chunk: 175

Company: NewGenIvf Group Ltd
Filing Date: 2025-03-07
Form: F-1
Chunk 175
---
200,000 Class A Ordinary Shares post Reverse Stock Split) for a purchase price of $1,181,898. On February 3, 2025, the Company issued 2,000,000 Class A Ordinary Shares (equivalent to 100,000 Class A Ordinary Shares post Reverse Stock Split) for a purchase price of $280,000. On February 7, 2025, the Company issued 4,000,000 Class A Ordinary Shares (equivalent to 200,000 Class A Ordinary Shares post Reverse Stock Split) for a purchase price of $431,068. On February 10, 2025, the Company issued 7,000,000 Class A Ordinary Shares (equivalent to 350,000 Class A Ordinary Shares post Reverse Stock Split) for a purchase price of $802,821. On February 20, 2025, the Company issued 125,000 Class A Ordinary Shares (on a post-Reverse Stock Split basis) for a purchase price of $261,822. On February 28, 2025, the Company issued 100,000 Class A Ordinary Shares (on a post-Reverse Stock Split basis) for a purchase price of $190,120. On March 3, 2025, the Company issued 25,000 Class A Ordinary Shares (on a post-Reverse Stock Split basis) for a purchase price of $34,678. The Company received gross proceeds of $6,827,681 and issued an aggregate of 1,605,000 Class A Ordinary Shares (on a post-Reverse Stock Split basis) to White Lion. MicroSort Acquisition On January 21, 2025, the Company entered into a Purchase Agreement with Genetics & IVF Insitute, Inc. (“Purchase Agreement”), pursuant to which the Company purchased all of the Assets (as defined in the Purchase Agreement) and IP Licenses (as defined in the Purchase Agreement) relating to the MicroSort Business (as defined in the Purchase Agreement) from Genetics & IVF Insitute, Inc. for a cash consideration of $750,000 and a share consideration of 125,000 Class A Ordinary Shares (“Share Consideration”). The Purchase Agreement is filed as Exhibit 10.30 in this registration statement. The MicroSort Acquisition closed on February 28, 2025, and the Share Consideration was issued to GIVF on the same day. ASPAC Consulting Services Agreement On February 24, 2025, the Company entered into